Table 1.

 Baseline patient characteristics for trabeculectomy and glaucoma drainage device (GDD) groups

Characteristics	Trabeculectomy	GDD	p Value
Sex
Male	15 (39%)	7 (32%)
Female	24 (61%)	15 (68%)	0.8
Race
White	16 (41.0)	11 (50.0)
Black	49 (10.3)	3 (13.6)
Asian	9 (23.1)	5 (22.7)
Latino	10 (25.6)	3 (13.6)	0.8
Age (years) (mean (SD))	69.5 (11.2)	71.4 (12.2)	0.55
Surgical procedure†	MMC 36 (92%)
	5-FU 2 (5%)	Complete 13 (59%)
	None 1 (3%)	Stage 2 9 (41%)
Lens status
Phakic	15 (38%)	4 (18%)
Pseudophakic	23 (59%)	18 (82%)
Aphakic	1 (3%)	0 (0%)	0.17
Diagnosis‡
POAG	32 (82%)	16 (73%)
2OAG	1 (2.5%)	4 (18%)
CACG	5 (13%)	0 (0%)
NVG	1 (2.5%)	2 (9%)	0.04*
Preoperative IOP (mm Hg) (mean (SD))	22.8 (9.7)	25.2 (8.4)	0.33

†MMC, mitomycin C trabeculectomy; 5-FU, 5-fluorouracil trabeculotomy; Complete, complete Baerveldt implant; Stage 2, second stage of Baerveldt implant.

‡POAG, primary open angle glaucoma; 2OAG, secondary open angle glaucoma; CACG, chronic angle closure glaucoma; NVG, neovascular glaucoma.